Consistent with these observations, the treatment with cysteamine did not normalize the circulating MCP-1 levels that were found significantly increased in the sera of patients with cystinosis compared with healthy donors, which strongly suggests that the absence of cystinosin, rather than cystine accumulation, is responsible for MCP-1 increase in serum [21]. Here, CCL2 is linked to cystinosis.